ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 4 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

1
Player Avatar rofgile (99.30) Submitted: 12/10/2010 12:25:25 AM : Underperform Start Price: $9.50 ISIS Score: -157.99

RNAi, please die.

Member Avatar TruffelPig (< 20) Submitted: 5/23/2014 8:14:24 PM
Recs: 1

Seems the only thing dying is your score. Cover now, good time!

Featured Broker Partners


Advertisement